Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Shin Nippon Biomedical Laboratories, Ltd.
| Okres |
2023-03-31 |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
| Przychód (średnia) |
25,083.54 |
26,450.47 |
30,500.00 |
34,000.00 |
37,500.00 |
| Przychód Δ r/r |
0.00% |
5.45% |
15.31% |
11.48% |
10.29% |
| Przychód (min) |
25,083.54 |
24,478.37 |
30,500.00 |
34,000.00 |
37,500.00 |
| Przychód (max) |
25,083.54 |
28,413.22 |
30,500.00 |
34,000.00 |
37,500.00 |
| EBITDA (średnia) |
8,914.47 |
9,400.27 |
10,839.43 |
12,083.30 |
13,327.17 |
| EBIT (średnia) |
7,089.58 |
7,475.93 |
8,620.49 |
9,609.72 |
10,598.96 |
| EBIT % |
28.26% |
28.26% |
28.26% |
28.26% |
28.26% |
| Zysk netto (średni) |
5,358.45 |
5,531.26 |
4,300.00 |
6,700.00 |
7,700.00 |
| Zysk netto % |
21.36% |
20.91% |
14.10% |
19.71% |
20.53% |
| EPS (średnia) |
128.71 |
132.86 |
103.30 |
160.90 |
185.00 |
| Liczba analityków (Przychody) |
0 |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
0 |
1 |
1 |
1 |
1 |
| symbol |
2395.T |
2395.T |
2395.T |
2395.T |
2395.T |